DOCSLIB.ORG

Desk Reference Guide

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Desk Reference Guide # Berbemycin CoQmax Ubiquinol GI Protect 5-HTP CR Benfotiamine Corticare B GlutAloeMine 5-MTHF Bio C 1:1 CurcuPlex CR Green Tea 600 5-MTHF ES Borage CP-240 GS 750 BrainSustain D A H BrainSustain for Kids D3 2000 ActivEssentials D3 5000 HistDAO ActivEssentials for Women C D3 Liquid Hormone Protect ActivEssentials with Calcium Calcium D-Glucarate DHA from Algae I Activ Essentials with OncoPLEX & D3 Candicidal DHA from Algae for Kids Desk i5 ActivNutrients Cardio Essentials DIMension 3 IgG 2000 DF Capsules ActivNutrients without Copper & Iron CarniteX DioVasc Reference IgG 2000 DF Powder ActivNutrients without Iron CheleX DJD Factors IgG Pure Guide Adrenal Essence CholeRex doloroX Immune Essentials AdrenaMax CinnDromeX ImmunoBar ALAmax CR Coconut Oil F ImmunotiX 250 AllerDHQ CodPure Plus FIT Food Vegan ImmunotiX 500 AngiNOX ColonX FIT Food Whey Iron Glycinate Appe-Curb ConjuLean 1000 G I-Sight Aromat8-PN coolsens CoQmax CF GarliX B GastrAcid J Updated: September 11, 2013 CoQmax-100 CF B Activ Joint Rx Click bottom right corner to return to Table of Contents Melatonin OmegaPure 600 EC RelaxMax K Melatonin CR OmegaPure 780 EC P Resveratin Plus X K2-45 MemorAll OmegaPure 820 PanXyme pH Xcellent C K2-D3 MenoFem OmegaPure DHA PepciX S Xcellent E HG-400 K-Mg Citrate Methylcobalamin OmegaPure EFA PhosphaLine S-Acetyl Glutathione XenoProtX Methyl Protect OmegaPure EPA PhosphaLine 4:1 Saccharomycin DF XymoDine L MinRex OmegaPure Liquid PMS Soothe Saloxicin XymoZyme Lacidol Mitochondrial Renewal Kit OncoMAR Prenatal Essentials SAMe & TMG LipiChol Z Mood Food OncoPLEX ProbioMax DF SedaLin LipotropiX Zinc Glycinate Mood Food ES OncoPLEX ES ProbioMax Daily DF Selen-E-400 Liver Protect OptiCleanse GHI ProbioMax DDS SerenX L-Glutamine N OptiCleanse Plus ProbioMax ENT L-Lysine T N.O.max ER OptiFiber SCFA ProbioMax ENT for Kids L-Theanine T-150 NAC OptiMag 125 ProbioMax Plus DF Nattokinase Probio Defense TestoPlex M OptiMetaboliX NeuroActives BrainSustain Oraxinol Prostate FLO Magnesium Citrate U NiaVasc OrganiX Bars ProteoXyme MedCaps DPO UritraX NiaVasc 750 OrganiX PhytoFood MedCaps GI R Nrf2 Activator OSAplex V MedCaps IS Red Yeast Rice OSAplex MK-7 VegaPro MedCaps Menopause O RegeneMax Ossopan 1100 Vinpocetine MedCaps T3 OmegaPure 300 EC RegeneMax Liquid Ossopan MD Viragraphis Table of Contents # Berbemycin CoQmax Ubiquinol GI Protect 5-HTP CR Benfotiamine Corticare B GlutAloeMine 5-MTHF Bio C 1:1 CurcuPlex CR Green Tea 600 5-MTHF ES Borage CP-240 GS 750 BrainSustain D A H BrainSustain for Kids D3 2000 ActivEssentials D3 5000 HistDAO ActivEssentials for Women C D3 Liquid Hormone Protect ActivEssentials with Calcium Calcium D-Glucarate DHA from Algae I Activ Essentials with OncoPLEX & D3 Candicidal DHA from Algae for Kids i5 ActivNutrients Cardio Essentials DIMension 3 IgG 2000 DF Capsules ActivNutrients without Copper & Iron CarniteX DioVasc IgG 2000 DF Powder ActivNutrients without Iron CheleX DJD Factors IgG Pure Adrenal Essence CholeRex doloroX Immune Essentials AdrenaMax CinnDromeX ImmunoBar ALAmax CR Coconut Oil F ImmunotiX 250 AllerDHQ CodPure Plus FIT Food Vegan ImmunotiX 500 AngiNOX ColonX FIT Food Whey Iron Glycinate Appe-Curb ConjuLean 1000 G I-Sight Aromat8-PN coolsens CoQmax CF GarliX B J CoQmax-100 CF GastrAcid B Activ Joint Rx Click bottom right corner to return to Table of Contents Melatonin OmegaPure 600 EC RelaxMax K Melatonin CR OmegaPure 780 EC P Resveratin Plus X K2-45 MemorAll OmegaPure 820 PanXyme pH Xcellent C K2-D3 MenoFem OmegaPure DHA PepciX S Xcellent E HG-400 K-Mg Citrate Methylcobalamin OmegaPure EFA PhosphaLine S-Acetyl Glutathione XenoProtX Methyl Protect OmegaPure EPA PhosphaLine 4:1 Saccharomycin DF XymoDine L MinRex OmegaPure Liquid PMS Soothe Saloxicin XymoZyme Lacidol Mitochondrial Renewal Kit OncoMAR Prenatal Essentials SAMe & TMG LipiChol Z Mood Food OncoPLEX ProbioMax DF SedaLin LipotropiX Zinc Glycinate Mood Food ES OncoPLEX ES ProbioMax Daily DF Selen-E-400 Liver Protect OptiCleanse GHI ProbioMax DDS SerenX L-Glutamine N OptiCleanse Plus ProbioMax ENT L-Lysine T N.O.max ER OptiFiber SCFA ProbioMax ENT for Kids L-Theanine T-150 NAC OptiMag 125 ProbioMax Plus DF Nattokinase Probio Defense TestoPlex M OptiMetaboliX NeuroActives BrainSustain Oraxinol Prostate FLO Magnesium Citrate U NiaVasc OrganiX Bars ProteoXyme MedCaps DPO UritraX NiaVasc 750 OrganiX PhytoFood MedCaps GI R Nrf2 Activator OSAplex V MedCaps IS Red Yeast Rice OSAplex MK-7 VegaPro MedCaps Menopause O RegeneMax Ossopan 1100 Vinpocetine MedCaps T3 OmegaPure 300 EC RegeneMax Liquid Ossopan MD Viragraphis Table of Contents # Berbemycin CoQmax Ubiquinol GI Protect 5-HTP CR Benfotiamine Corticare B GlutAloeMine 5-MTHF Bio C 1:1 CurcuPlex CR Green Tea 600 5-MTHF ES Borage CP-240 GS 750 BrainSustain D A H BrainSustain for Kids D3 2000 HistDAO ActivEssentials D3 5000 Hormone Protect ActivEssentials for Women C D3 Liquid Calcium D-Glucarate ActivEssentials with Calcium D3 Vegan 1000 Candicidal I Activ Essentials with OncoPLEX & D3 DHA from Algae Cardio Essentials i5 ActivNutrients DHA from Algae for Kids CarniteX IgG 2000 DF Capsules ActivNutrients without Copper & Iron DIMension 3 IgG 2000 DF Powder ActivNutrients without Iron CheleX DioVasc IgG Pure Adrenal Essence CholeRex DJD Factors Immune Essentials AdrenaMax CinnDromeX ImmunoBar ALAmax CR Coconut Oil F ImmunotiX 250 AllerDHQ CodPure Plus FIT Food Vegan ImmunotiX 500 AngiNOX ColonX FIT Food Whey InSea2 Appe-Curb ConjuLean 1000 Iron Glycinate Aromat8-PN coolsens G CoQmax CF I-Sight B GarliX CoQmax-100 CF B Activ GastrAcid J Joint Rx Click bottom right corner to return to Table of Contents Melatonin OmegaPure 600 EC RelaxMax K Melatonin CR OmegaPure 780 EC P Resveratin Plus X K2-45 MemorAll OmegaPure 820 PanXyme pH Xcellent C K2-D3 MenoFem OmegaPure DHA PepciX S Xcellent E HG-400 K-Mg Citrate Methylcobalamin OmegaPure EFA PhosphaLine S-Acetyl Glutathione XenoProtX Methyl Protect OmegaPure EPA PhosphaLine 4:1 Saccharomycin DF XymoDine L MinRex OmegaPure Liquid PMS Soothe Saloxicin XymoZyme Lacidol Mitochondrial Renewal Kit OncoMAR Prenatal Essentials SAMe & TMG LipiChol Z Mood Food OncoPLEX ProbioMax DF SedaLin LipotropiX Zinc Glycinate Mood Food ES OncoPLEX ES ProbioMax Daily DF Selen-E-400 Liver Protect OptiCleanse GHI ProbioMax DDS SerenX L-Glutamine N OptiCleanse Plus ProbioMax ENT L-Lysine T N.O.max ER OptiFiber SCFA ProbioMax ENT for Kids L-Theanine T-150 NAC OptiMag 125 ProbioMax Plus DF Nattokinase Probio Defense TestoPlex M OptiMetaboliX NeuroActives BrainSustain Oraxinol Prostate FLO Magnesium Citrate U NiaVasc OrganiX Bars ProteoXyme MedCaps DPO UritraX NiaVasc 750 OrganiX PhytoFood MedCaps GI R Nrf2 Activator OSAplex V MedCaps IS Red Yeast Rice OSAplex MK-7 VegaPro MedCaps Menopause O RegeneMax Ossopan 1100 Vinpocetine MedCaps T3 OmegaPure 300 EC RegeneMax Liquid Ossopan MD Viragraphis # Berbemycin CoQmax Ubiquinol GI Protect 5-HTP CR Benfotiamine Corticare B GlutAloeMine 5-MTHF Bio C 1:1 CurcuPlex CR Green Tea 600 5-MTHF ES Borage CP-240 GS 750 BrainSustain D A H BrainSustain for Kids D3 2000 ActivEssentials D3 5000 HistDAO ActivEssentials for Women C D3 Liquid Hormone Protect ActivEssentials with Calcium Calcium D-Glucarate DHA from Algae I Activ Essentials with OncoPLEX & D3 Candicidal DHA from Algae for Kids i5 ActivNutrients Cardio Essentials DIMension 3 IgG 2000 DF Capsules ActivNutrients without Copper & Iron CarniteX DioVasc IgG 2000 DF Powder ActivNutrients without Iron CheleX DJD Factors IgG Pure Adrenal Essence CholeRex doloroX Immune Essentials AdrenaMax CinnDromeX ImmunoBar ALAmax CR Coconut Oil F ImmunotiX 250 AllerDHQ CodPure Plus FIT Food Vegan ImmunotiX 500 AngiNOX ColonX FIT Food Whey Iron Glycinate Appe-Curb ConjuLean 1000 G I-Sight Aromat8-PN coolsens CoQmax CF GarliX B J CoQmax-100 CF GastrAcid B Activ Joint Rx Table of Contents Melatonin OmegaPure 600 EC RelaxMax K Melatonin CR OmegaPure 780 EC P Resveratin Plus X K2-45 MemorAll OmegaPure 820 PanXyme pH Xcellent C K2-D3 MenoFem OmegaPure DHA PepciX S Xcellent E HG-400 K-Mg Citrate Methylcobalamin OmegaPure EFA PhosphaLine S-Acetyl Glutathione XenoProtX Methyl Protect OmegaPure EPA PhosphaLine 4:1 Saccharomycin DF XymoDine L MinRex OmegaPure Liquid PMS Soothe Saloxicin XymoZyme Lacidol Mitochondrial Renewal Kit OncoMAR Prenatal Essentials SAMe & TMG LipotropiX Z Mood Food OncoPLEX ProbioMax DF SedaLin Liver Protect Zinc Glycinate Mood Food ES OncoPLEX ES ProbioMax Daily DF Selen-E-400 L-Glutamine OptiCleanse GHI ProbioMax DDS SerenX L-Lysine N OptiCleanse Plus ProbioMax ENT L-Theanine T N.O.max ER OptiFiber SCFA ProbioMax ENT for Kids T-150 NAC OptiMag 125 ProbioMax Plus DF Nattokinase Probio Defense TestoPlex M OptiMetaboliX NeuroActives BrainSustain Oraxinol Prostate FLO Magnesium Citrate U NiaVasc OrganiX Bars ProteoXyme MedCaps DPO UritraX NiaVasc 750 OrganiX PhytoFood MedCaps GI R Nrf2 Activator OSAplex V MedCaps IS Red Yeast Rice OSAplex MK-7 VegaPro MedCaps Menopause O RegeneMax Ossopan 1100 Vinpocetine MedCaps T3 OmegaPure 300 EC RegeneMax Liquid Ossopan MD Viragraphis Click bottom right corner to return to Table of Contents # Berbemycin CoQmax Ubiquinol GI Protect 5-HTP CR Benfotiamine Corticare B GlutAloeMine 5-MTHF Bio C 1:1 CurcuPlex CR Green Tea 600 5-MTHF ES Borage CP-240 GS 750 BrainSustain D A H BrainSustain for Kids D3 2000 ActivEssentials D3 5000 HistDAO ActivEssentials for Women C D3 Liquid Hormone Protect ActivEssentials with Calcium Calcium D-Glucarate DHA from Algae I Activ Essentials with OncoPLEX & D3 Candicidal DHA from Algae for Kids i5 ActivNutrients Cardio Essentials DIMension
Load more

Recommended publications
  • The National Drugs List
    ^ ^ ^ ^ ^[ ^ The National Drugs List Of Syrian Arab Republic Sexth Edition 2006 ! " # "$ % &'() " # * +$, -. / & 0 /+12 3 4" 5 "$ . "$ 67"5,) 0 " /! !2 4? @ % 88 9 3: " # "$ ;+<=2 – G# H H2 I) – 6( – 65 : A B C "5 : , D )* . J!* HK"3 H"$ T ) 4 B K<) +$ LMA N O 3 4P<B &Q / RS ) H< C4VH /430 / 1988 V W* < C A GQ ") 4V / 1000 / C4VH /820 / 2001 V XX K<# C ,V /500 / 1992 V "!X V /946 / 2004 V Z < C V /914 / 2003 V ) < ] +$, [2 / ,) @# @ S%Q2 J"= [ &<\ @ +$ LMA 1 O \ . S X '( ^ & M_ `AB @ &' 3 4" + @ V= 4 )\ " : N " # "$ 6 ) G" 3Q + a C G /<"B d3: C K7 e , fM 4 Q b"$ " < $\ c"7: 5) G . HHH3Q J # Hg ' V"h 6< G* H5 !" # $%" & $' ,* ( )* + 2 ا اوا ادو +% 5 j 2 i1 6 B J' 6<X " 6"[ i2 "$ "< * i3 10 6 i4 11 6! ^ i5 13 6<X "!# * i6 15 7 G!, 6 - k 24"$d dl ?K V *4V h 63[46 ' i8 19 Adl 20 "( 2 i9 20 G Q) 6 i10 20 a 6 m[, 6 i11 21 ?K V $n i12 21 "% * i13 23 b+ 6 i14 23 oe C * i15 24 !, 2 6\ i16 25 C V pq * i17 26 ( S 6) 1, ++ &"r i19 3 +% 27 G 6 ""% i19 28 ^ Ks 2 i20 31 % Ks 2 i21 32 s * i22 35 " " * i23 37 "$ * i24 38 6" i25 39 V t h Gu* v!* 2 i26 39 ( 2 i27 40 B w< Ks 2 i28 40 d C &"r i29 42 "' 6 i30 42 " * i31 42 ":< * i32 5 ./ 0" -33 4 : ANAESTHETICS $ 1 2 -1 :GENERAL ANAESTHETICS AND OXYGEN 4 $1 2 2- ATRACURIUM BESYLATE DROPERIDOL ETHER FENTANYL HALOTHANE ISOFLURANE KETAMINE HCL NITROUS OXIDE OXYGEN PROPOFOL REMIFENTANIL SEVOFLURANE SUFENTANIL THIOPENTAL :LOCAL ANAESTHETICS !67$1 2 -5 AMYLEINE HCL=AMYLOCAINE ARTICAINE BENZOCAINE BUPIVACAINE CINCHOCAINE LIDOCAINE MEPIVACAINE OXETHAZAINE PRAMOXINE PRILOCAINE PREOPERATIVE MEDICATION & SEDATION FOR 9*: ;< " 2 -8 : : SHORT -TERM PROCEDURES ATROPINE DIAZEPAM INJ.
    [Show full text]
  • Premenstrual Syndrome: a Natural Approach to Management
    CNI506 8/99 Vol. 5, No. 6 APPLIED NUTRITIONAL SCIENCE REPORTS Copyright © 1997 Advanced Nutrition Publications, Inc. rev. 1999 Premenstrual Syndrome: A Natural Approach to Management BY JOSEPH L. MAYO, MD, FACOG ABSTRACT: Premenstrual syndrome (PMS) is a disorder that imbalances, nutritional insufficiencies, and psychologic factors. occurs during the luteal phase of the menstrual cycle, producing A nutritional approach to PMS that takes into account the complex a diverse number of physical and emotional changes. The most interactions of all bodily systems that influence hormonal balance common symptoms of PMS include bloating, backache, breast and neuroendocrine function, with an emphasis on the liver, is tenderness, food cravings, fatigue, irritability, and depression. recommended. The nutritional factors that have been studied The timing of the appearance and disappearance of symptoms, include vitamin B6, magnesium, zinc, choline, vitamin E, and rather than the presence of specific symptoms, is of more essential fatty acids, in addition to weight management and importance in the diagnosis of PMS. The direct cause of PMS is stress reduction. Herbal therapies have also proven beneficial in unknown, although there are numerous theories relating to hormonal the management of PMS. PREMENSTRUAL SYNDROME symptoms such as bloating, breast tenderness, and headache (Table 1).3-5 These diverse symptoms may range from mild Cyclic symptoms in women of reproductive age have been to incapacitating. In some women a single symptom, such recognized for thousands of years. First appearing in the medical as depression, may predominate, whereas others may have literature in 1931 and originally termed “premenstrual tension,” several symptoms.1 this condition has been renamed “premenstrual syndrome” (PMS) in an effort to take into account the different clinical Table.
    [Show full text]
  • HANDBOOK of Medicinal Herbs SECOND EDITION
    HANDBOOK OF Medicinal Herbs SECOND EDITION 1284_frame_FM Page 2 Thursday, May 23, 2002 10:53 AM HANDBOOK OF Medicinal Herbs SECOND EDITION James A. Duke with Mary Jo Bogenschutz-Godwin Judi duCellier Peggy-Ann K. Duke CRC PRESS Boca Raton London New York Washington, D.C. Peggy-Ann K. Duke has the copyright to all black and white line and color illustrations. The author would like to express thanks to Nature’s Herbs for the color slides presented in the book. Library of Congress Cataloging-in-Publication Data Duke, James A., 1929- Handbook of medicinal herbs / James A. Duke, with Mary Jo Bogenschutz-Godwin, Judi duCellier, Peggy-Ann K. Duke.-- 2nd ed. p. cm. Previously published: CRC handbook of medicinal herbs. Includes bibliographical references and index. ISBN 0-8493-1284-1 (alk. paper) 1. Medicinal plants. 2. Herbs. 3. Herbals. 4. Traditional medicine. 5. Material medica, Vegetable. I. Duke, James A., 1929- CRC handbook of medicinal herbs. II. Title. [DNLM: 1. Medicine, Herbal. 2. Plants, Medicinal.] QK99.A1 D83 2002 615′.321--dc21 2002017548 This book contains information obtained from authentic and highly regarded sources. Reprinted material is quoted with permission, and sources are indicated. A wide variety of references are listed. Reasonable efforts have been made to publish reliable data and information, but the author and the publisher cannot assume responsibility for the validity of all materials or for the consequences of their use. Neither this book nor any part may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, microfilming, and recording, or by any information storage or retrieval system, without prior permission in writing from the publisher.
    [Show full text]
  • Dietary Supplements Compendium Volume 1
    2015 Dietary Supplements Compendium DSC Volume 1 General Notices and Requirements USP–NF General Chapters USP–NF Dietary Supplement Monographs USP–NF Excipient Monographs FCC General Provisions FCC Monographs FCC Identity Standards FCC Appendices Reagents, Indicators, and Solutions Reference Tables DSC217M_DSCVol1_Title_2015-01_V3.indd 1 2/2/15 12:18 PM 2 Notice and Warning Concerning U.S. Patent or Trademark Rights The inclusion in the USP Dietary Supplements Compendium of a monograph on any dietary supplement in respect to which patent or trademark rights may exist shall not be deemed, and is not intended as, a grant of, or authority to exercise, any right or privilege protected by such patent or trademark. All such rights and privileges are vested in the patent or trademark owner, and no other person may exercise the same without express permission, authority, or license secured from such patent or trademark owner. Concerning Use of the USP Dietary Supplements Compendium Attention is called to the fact that USP Dietary Supplements Compendium text is fully copyrighted. Authors and others wishing to use portions of the text should request permission to do so from the Legal Department of the United States Pharmacopeial Convention. Copyright © 2015 The United States Pharmacopeial Convention ISBN: 978-1-936424-41-2 12601 Twinbrook Parkway, Rockville, MD 20852 All rights reserved. DSC Contents iii Contents USP Dietary Supplements Compendium Volume 1 Volume 2 Members . v. Preface . v Mission and Preface . 1 Dietary Supplements Admission Evaluations . 1. General Notices and Requirements . 9 USP Dietary Supplement Verification Program . .205 USP–NF General Chapters . 25 Dietary Supplements Regulatory USP–NF Dietary Supplement Monographs .
    [Show full text]
  • Pharmaceutical Appendix to the Tariff Schedule 2
    Harmonized Tariff Schedule of the United States (2007) (Rev. 2) Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2007) (Rev. 2) Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 2 Table 1. This table enumerates products described by International Non-proprietary Names (INN) which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service (CAS) registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known. ABACAVIR 136470-78-5 ACIDUM LIDADRONICUM 63132-38-7 ABAFUNGIN 129639-79-8 ACIDUM SALCAPROZICUM 183990-46-7 ABAMECTIN 65195-55-3 ACIDUM SALCLOBUZICUM 387825-03-8 ABANOQUIL 90402-40-7 ACIFRAN 72420-38-3 ABAPERIDONUM 183849-43-6 ACIPIMOX 51037-30-0 ABARELIX 183552-38-7 ACITAZANOLAST 114607-46-4 ABATACEPTUM 332348-12-6 ACITEMATE 101197-99-3 ABCIXIMAB 143653-53-6 ACITRETIN 55079-83-9 ABECARNIL 111841-85-1 ACIVICIN 42228-92-2 ABETIMUSUM 167362-48-3 ACLANTATE 39633-62-0 ABIRATERONE 154229-19-3 ACLARUBICIN 57576-44-0 ABITESARTAN 137882-98-5 ACLATONIUM NAPADISILATE 55077-30-0 ABLUKAST 96566-25-5 ACODAZOLE 79152-85-5 ABRINEURINUM 178535-93-8 ACOLBIFENUM 182167-02-8 ABUNIDAZOLE 91017-58-2 ACONIAZIDE 13410-86-1 ACADESINE 2627-69-2 ACOTIAMIDUM 185106-16-5 ACAMPROSATE 77337-76-9
    [Show full text]
  • Systematic Evidence Review from the Blood Pressure Expert Panel, 2013
    Managing Blood Pressure in Adults Systematic Evidence Review From the Blood Pressure Expert Panel, 2013 Contents Foreword ............................................................................................................................................ vi Blood Pressure Expert Panel ..............................................................................................................vii Section 1: Background and Description of the NHLBI Cardiovascular Risk Reduction Project ............ 1 A. Background .............................................................................................................................. 1 Section 2: Process and Methods Overview ......................................................................................... 3 A. Evidence-Based Approach ....................................................................................................... 3 i. Overview of the Evidence-Based Methodology ................................................................. 3 ii. System for Grading the Body of Evidence ......................................................................... 4 iii. Peer-Review Process ....................................................................................................... 5 B. Critical Question–Based Approach ........................................................................................... 5 i. How the Questions Were Selected ................................................................................... 5 ii. Rationale for the Questions
    [Show full text]
  • Analytical Reference Standards
    Cerilliant Quality ISO GUIDE 34 ISO/IEC 17025 ISO 90 01:2 00 8 GM P/ GL P Analytical Reference Standards 2 011 Analytical Reference Standards 20 811 PALOMA DRIVE, SUITE A, ROUND ROCK, TEXAS 78665, USA 11 PHONE 800/848-7837 | 512/238-9974 | FAX 800/654-1458 | 512/238-9129 | www.cerilliant.com company overview about cerilliant Cerilliant is an ISO Guide 34 and ISO 17025 accredited company dedicated to producing and providing high quality Certified Reference Standards and Certified Spiking SolutionsTM. We serve a diverse group of customers including private and public laboratories, research institutes, instrument manufacturers and pharmaceutical concerns – organizations that require materials of the highest quality, whether they’re conducing clinical or forensic testing, environmental analysis, pharmaceutical research, or developing new testing equipment. But we do more than just conduct science on their behalf. We make science smarter. Our team of experts includes numerous PhDs and advance-degreed specialists in science, manufacturing, and quality control, all of whom have a passion for the work they do, thrive in our collaborative atmosphere which values innovative thinking, and approach each day committed to delivering products and service second to none. At Cerilliant, we believe good chemistry is more than just a process in the lab. It’s also about creating partnerships that anticipate the needs of our clients and provide the catalyst for their success. to place an order or for customer service WEBSITE: www.cerilliant.com E-MAIL: [email protected] PHONE (8 A.M.–5 P.M. CT): 800/848-7837 | 512/238-9974 FAX: 800/654-1458 | 512/238-9129 ADDRESS: 811 PALOMA DRIVE, SUITE A ROUND ROCK, TEXAS 78665, USA © 2010 Cerilliant Corporation.
    [Show full text]
  • Pharmacological and Therapeutic Effects of Vitex Agnus‑Castus L.: a Review
    Pharmacogn. Rev. PLANT REVIEW A multifaceted peer reviewed journal in the field of Pharmacognosy and Natural Products www.phcogrev.com | www.phcog.net Pharmacological and Therapeutic Effects ofVitex agnus-castus L.: A Review Mina Cheraghi Niroumand, Fatemeh Heydarpour1, Mohammad Hosein Farzaei2,3 Deputy of Persian Medicine, Ministry of Health and Medical Education, Tehran, 1Department of Epidemiology, Faculty of Public Health, Kermanshah University of Medical Sciences, Kermanshah, 2Pharmaceutical Sciences Research Center, Kermanshah University of Medical Sciences, Kermanshah, 3Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran ABSTRACT Vitex agnus-castus L., known as the chaste tree, is a small deciduous tree which its fruits have been used for more than 2500 years in ancient Egypt, Greece, Iran, and Rome for a variety of gynecologic problems. It has also been used for its claimed activity in the reduction of libido. The German health authorities have approved the use of V. agnus-castus for menstrual cycle irregularities, premenstrual syndrome, mastalgia, and menopausal disorders. The German Commission E recommended 30–40 mg/day of extract of dried fruit which is standardized based on 0.6% casticin. Scientific studies confirmed several pharmaceutical effects of this medicinal plant including antioxidant, chemopreventive, immunomodulatory and cytotoxicity, tumoricidal, antimutagenic, antimicrobial, antifungal, insect repellant, larvicidal, fracture healing, osteopenic, antinociceptive, opioidergic, antiepileptic, preventing nonalcoholic fat liver disease and oxidative stress, and anti‑inflammatory activities. Adverse effects following by application of this plant are mild and reversible. There are no drug interactions recognized by systematic reviews. Theoretically, chaste tree could interfere with dopaminergic antagonists. In addition, the application of V.
    [Show full text]
  • Study Protocol and Statistical Analysis Plan
    Multicenter double-blind placebo-controlled randomized parallel-group clinical study of efficacy and safety of MMH-MAP in the treatment of mild cognitive impairment in subjects in early rehabilitation period of ischemic stroke Phase III Sponsor OOO «NPF «MATERIA MEDICA HOLDING» Protocol number MMH-MAP-001 Version date: August 29, 2018 ClinicalTrials.gov Id: NCT03815292 Protocol No. MMH-MAP-001 29-Aug-2018 Protocol Summary This document represents the protocol summary for the study on human subjects. The study will be carried out in accordance with ICH GCP, National Standard of the Russian Federation GOST 52379-2005 "Good Clinical Practice", World Medical Association Declaration of Helsinki, relevant requirements of the regulatory authorities as well as the study procedures. Title of Study Multicenter double-blind placebo-controlled randomized parallel-group clinical study of efficacy and safety of MMH-MAP in the treatment of mild cognitive impairment in subjects in early rehabilitation period of ischemic stroke. Phase: III Sponsor: Company «MATERIA MEDICA HOLDING», Moscow, Russia Protocol No. MMH-MAP-001 Objective of the study To evaluate efficacy of MMH-MAP in the treatment of mild cognitive impairment in subjects in early rehabilitation period of ischemic stroke. To evaluate the safety of MMH-MAP in the treatment of mild cognitive impairment in subjects in early rehabilitation period of ischemic stroke. Endpoints Primary endpoint 1. Proportion of subjects with improved cognitive functions (MoCA ≥ +1) after 24-week therapy compared to baseline. Secondary endpoints 1. Change in MoCA scores after 24 weeks of treatment. 2. Percentage of patients with improved performance in activities of daily living (total Barthel Index score + 5 or more) after 24 weeks of treatment.
    [Show full text]
  • Known Bioactive Library: Microsource 1 - US Drug Collection
    Known Bioactive Library: Microsource 1 - US Drug Collection ICCB-L ICCB-L Vendor Vendor Compound Name Bioactivity Source CAS Plate Well ID antifungal, inhibits Penicillium 2091 A03 Microsource 00200046 GRISEOFULVIN 126-07-8 mitosis in metaphase griseofulvum 3505-38-2, 486-16-8 2091 A04 Microsource 01500161 CARBINOXAMINE MALEATE antihistaminic synthetic [carbinoxamine] 2091 A05 Microsource 00200331 SALSALATE analgesic synthetic 552-94-3 muscle relaxant 2091 A06 Microsource 01500162 CARISOPRODOL synthetic 78-44-4 (skeletal) antineoplastic, 2091 A07 Microsource 00210369 GALLIC ACID insect galls 149-91-7 astringent, antibacterial 66592-87-8, 50370-12- 2091 A08 Microsource 01500163 CEFADROXIL antibacterial semisynthetic 2 [anhydrous], 119922- 89-9 [hemihydrate] Rheum palmatum, 2091 A09 Microsource 00211468 DANTHRON cathartic 117-10-2 Xyris semifuscata 27164-46-1, 25953-19- 2091 A10 Microsource 01500164 CEFAZOLIN SODIUM antibacterial semisynthetic 9 [cefazolin] glucocorticoid, 2091 A11 Microsource 00300024 HYDROCORTISONE adrenal glands 50-23-7 antiinflammatory 64485-93-4, 63527-52- 2091 A12 Microsource 01500165 CEFOTAXIME SODIUM antibacterial semisynthetic 6 [cefotaxime] 2091 A13 Microsource 00300029 DESOXYCORTICOSTERONE ACETATE mineralocorticoid adrenocortex 56-47-3 58-71-9, 153-61-7 2091 A14 Microsource 01500166 CEPHALOTHIN SODIUM antibacterial semisynthetic [cephalothin] 2091 A15 Microsource 00300034 TESTOSTERONE PROPIONATE androgen, antineoplastic semisynthetic 57-85-2 24356-60-3, 21593-23- 2091 A16 Microsource 01500167 CEPHAPIRIN SODIUM
    [Show full text]
  • Vitex ​Agnus-Castus
    REFERENCE SHEET: Vitex ​agnus-castus Pronunciation Vitex agnus-castus​​ (vy-teks ag-nus​ kast-us​) Summary Vitex agnus-castus​​ (VAC) is also commonly known as chaste tree or chasteberry. The plant’s main constituents include vitexin, casticin, agnuside, p-hydroxybenzoic acid, alkaloids, and diterpenoids. The fruit consists of flavonoids, terpenoids, neolignans, phenolic compounds, and glycerides. The extracts of the dried ripe fruits themselves demonstrate antioxidant activity and have been used in treating symptoms of premenstrual syndrome (PMS). Essential oils from the fruit contain 20.73–23.36% 1,8-cineole + 16.09–22.28% sabinene, and 6.60–19.73% α-pinene. Its main flavonoids include casticin, vitexin, and orientin. Standardized extracts typically measure the iridoid or flavonoid content where aucubin (iridoid glycoside) or agnuside is used as the reference material. Vitex agnus-castus​​ ​Reference Sheet Main Medical Uses Research supports the use of VAC in treating the symptoms of PMS, premenstrual dysphoric disorder, premenstrual migraines, premenstrual tension syndrome, postmenopausal hot flushes, cyclical mastalgia and hyperprolactinemia. Evidence also demonstrates similar effectiveness of VAC to low dose oral contraceptives and metformin in polycystic ovarian syndrome, and to ethinyl estradiol/drospirenone in dysmenorrhea. VAC can reduce intrauterine device induced bleeding, and may promote the healing of fractures. Proprietary Extracts Proprietary Extract Formulation Safety VAC BNO 1095 70% ethanol, 30% H2O extract No adverse
    [Show full text]
  • BMJ Open Is Committed to Open Peer Review. As Part of This Commitment We Make the Peer Review History of Every Article We Publish Publicly Available
    BMJ Open: first published as 10.1136/bmjopen-2020-039747 on 22 October 2020. Downloaded from BMJ Open is committed to open peer review. As part of this commitment we make the peer review history of every article we publish publicly available. When an article is published we post the peer reviewers’ comments and the authors’ responses online. We also post the versions of the paper that were used during peer review. These are the versions that the peer review comments apply to. The versions of the paper that follow are the versions that were submitted during the peer review process. They are not the versions of record or the final published versions. They should not be cited or distributed as the published version of this manuscript. BMJ Open is an open access journal and the full, final, typeset and author-corrected version of record of the manuscript is available on our site with no access controls, subscription charges or pay-per-view fees (http://bmjopen.bmj.com). If you have any questions on BMJ Open’s open peer review process please email [email protected] http://bmjopen.bmj.com/ on September 26, 2021 by guest. Protected copyright. BMJ Open BMJ Open: first published as 10.1136/bmjopen-2020-039747 on 22 October 2020. Downloaded from Development and internal validation of prognostic models to predict negative health outcomes in older patients with multimorbidity and polypharmacy in general practice ForJournal: peerBMJ Open review only Manuscript ID bmjopen-2020-039747 Article Type: Original research Date Submitted by the 24-Apr-2020
    [Show full text]